Table 3.
Baseline characteristics of three clusters.
| Cluster 1 (n = 112) | Cluster 2 (n = 82) | Cluster 3 (n = 19) | P | |
|---|---|---|---|---|
| Gender (Male, %) | 63 (56.3%) | 43 (52.4%) | 10 (52.6) | 0.620 |
| Age (years) | 72.7 (6.7) | 54.1 (5.8) | 31.4 (12.2) | <0.001 |
| D-Dimer (mg/L) | 0.9 (0.4–3.5) | 0.3 (0.2–0.6) | 0.3 (0.1–0.6) | <0.001 |
| FIB (g/L) | 4.1 (1.4) | 4.3 (1.6) | 4.1 (1.2) | 0.773 |
| APTT (s) | 36.3 (23.6–40.6) | 34.5 (31.8–37.2) | 35.6 (33.4–41.8) | 0.082 |
| PT (s) | 13.2 (12.5–14.4) | 13.0 (12.4–13.9) | 12.9 (12.5–13.7) | 0.220 |
| WBC (×109/L) | 6.7 (5.2–9.3) | 6.8 (4.8–9.3) | 6.3 (5.2–9.1) | 0.771 |
| Neutrophil count (×109/L) | 5.1 (3.7–8.0) | 5.0 (3.0–7.8) | 3.7 (2.8–4.9) | 0.029 |
| Lymphocyte count (×109/L) | 0.8 (0.5–1.3) | 1.0 (0.6–1.7) | 1.5 (0.9–2.3) | 0.001 |
| Monocyte count (×109/L) | 0.4 (0.2) | 0.4 (0.2) | 0.4 (0.1) | 0.293 |
| Alanine aminotransferase (μ/L) | 26.5 (16.3–43.8) | 28.5 (17–40.5) | 19 (11–32) | 0.16 |
| Aspartate aminotransferase (μ/L) | 29 (20–44.8) | 23.5 (16–40.2) | 19 (14–32) | 0.009 |
| Albumin (g/L) | 34.8 (5.2) | 37.3 (5.1) | 37.9 (6.6) | 0.002 |
| Creatinine (μmol/L) | 70 (58–89) | 66.5 (53.8–78) | 73 (52–78) | 0.205 |
| Helper T lymphocyte count (n/μl) | 237.0 (85.2–422.5) | 262.4 (142.7–652.7) | 366.0 (274.4–696.8) | 0.003 |
| Cytotoxic T lymphocyte count (n/μl) | 115.4 (51.0–239.8) | 189.9 (97.8–387.8) | 316.4 (164.3–498.8) | <0.001 |
| CRP (mg/L) | 44.4 (15.0–85.1) | 22.6 (1.0–83.0) | 19.5 (1.0–31) | 0.002 |
| PCT (ng/ml) | 0.0 (0.0–0.1) | 0.0 (0.0–0.1) | 0.0 (0.0–0.1) | 0.065 |
| TNI (ng/ml) | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) | 0.015 |
| NT-proBNP (pg/ml) | 390 (94.8–875.6) | 48.5 (15–188) | 15 (15–292) | <0.001 |
CRP, C-reactive protein; PCT, procalcitonin; NT-pro BNP, N-terminal pro brain natriuretic peptide; TNI, troponinI; FIB, fibrinogen; APTT, anginal partial thromboplastin time; PT, prothrombin time; WBC, white blood cell.